NCT00329329View on ClinicalTrials.gov

Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies

PHASE1TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

February 28, 2009

Conditions
Malignancies
Interventions
DRUG

satraplatin and capecitabine

satraplatin and capecitabine dose escalated per the dosing scheme

Trial Locations (1)

60611

Northwestern University Medical Center, Chicago

Sponsors

Lead Sponsor

Agennix
All Listed Sponsors
lead

Agennix

INDUSTRY

NCT00329329 - Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies | Biotech Hunter | Biotech Hunter